Vilya CEO Cyrus Harmon (Vilya Photo) Vilya, a biotech startup built off technology developed at the Seattle-based Institute for Protein Design, announced
Recursion Pharmaceuticals, Inc. announced that Robert Hershberg, M.D., Ph.D, has been appointed the new Chair of the Board of the company, effective at the end of this term, as Martin Chavez exits.
Recursion Appoints Robert Hershberg M D , Ph D, as New Chair of the Board marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
KUOW - UW biochemistry professor makes list of top 100 global health leaders kuow.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kuow.org Daily Mail and Mail on Sunday newspapers.